Biopharma thesis starting to move away from obesity drugs, says Mizuho’s Jared Holz

Biopharma thesis starting to move away from obesity drugs, says Mizuho’s Jared Holz

March 20, 2026

Jared Holz, Mizuho, joins ‘Fast Money’ to talk the future of the obesity drug trade on new data out of Novo Nordisk Wegovy trials.

‍

Share This

Latest Mizuho News

Mizuho Securities Analyst on Latest with Oil and Gas Amid Middle East Conflict

Mizuho Securities Analyst on Latest with Oil and Gas Amid Middle East Conflict

March 13, 2026

Mizuho awarded Coalition Greenwich 2026 Best Bank distinctions in the U.S.

Mizuho awarded Coalition Greenwich 2026 Best Bank distinctions in the U.S.

March 17, 2026

Selective opportunities in software stocks amid sell-off, says Mizuho’s Gregg Moskowitz

Selective opportunities in software stocks amid sell-off, says Mizuho’s Gregg Moskowitz

February 17, 2026

Mizuho news from around the globe

Mizuho Global News